Sunday 18 October 2026
Export FENC’s income statement to Excel — free account
Adherex Technologies Inc.
FENC Healthcare Biotechnology
Adherex Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.6 million, down 6.09% from fiscal 2024. In the quarter to June 2026, revenue grew 85.2%, EPS grew 154.6% and free cash flow grew 101.4%, each against the same quarter a year earlier.
9.98
0.37
−3.57%
Follow FENC
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
1 | 1 | 6 | 6 |
| 143.64% | (65.82%) | (52.68%) | (18.58%) | ||
| (12.83%) | (16.87%) | (14.17%) | (5.39%) | ||
ROIC |
0.00% | 0.00% | 0.00% | (58.89%) | |
Return on Tangible Assets |
(19.15%) | (17.23%) | (14.62%) | (5.41%) | |
Average Days of Receivables |
182.01 | 189.86 | 134.28 | 143.40 | |
Free Cash Flow per Share |
(0.29) | (0.44) | (0.17) | (0.06) | |
Free Cash Flow |
(7.98) | (12.47) | (5.78) | (2.04) | |
| Other line items | |||||
Cash ROIC |
(22.45%) | (17.26%) | (7.42%) | (2.44%) | |
Accounts Receivable Turnover |
2.41 | 2.47 | 2.98 | 2.91 | |
Accounts Payable Turnover |
0.55 | 0.96 | 0.69 | 0.65 | |
Inventory Turnover |
1.48 | 2.87 | 2.43 | 1.62 | |
Average Days of Payables |
802.21 | 449.46 | 578.78 | 541.95 | |
Days of Inventory on Hand |
338.74 | 151.76 | 171.03 | 233.25 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.72% | 0.56% | 0.40% | 0.36% | |
Selling, General and Administrative Expense of Revenue |
104.42% | 105.08% | 102.80% | 95.26% | |
Share Based Compensation of Revenue |
14.53% | 15.75% | 14.17% | 12.67% | |
Interest Coverage |
(1.70) | (3.02) | (3.74) | (1.24) | |
Operating CF/Net income |
1.15 | 1.28 | 0.69 | 0.63 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
1.39 | 1.56 | 1.49 | 1.71 | |
Operating CF per Share |
(0.29) | (0.44) | (0.17) | (0.06) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates